liver
toxic
hepatotox
critic
issu
drug
discoveri
develop
standard
preclin
evalu
drug
hepatotox
gener
perform
use
vivo
anim
system
howev
small
number
preselect
compound
examin
vivo
due
high
experiment
cost
effici
yet
accur
screen
techniqu
identifi
potenti
hepatotox
compound
earli
stage
drug
develop
would
thu
valuabl
develop
appli
novel
genom
predict
techniqu
screen
hepatotox
compound
base
vitro
human
liver
cell
test
use
train
set
vivo
rodent
experi
drug
hepatotox
evalu
discov
common
biomark
druginduc
liver
toxic
among
six
heterogen
compound
gene
set
triag
subset
gene
use
multigen
express
signatur
predict
hepatotox
multigen
predictor
independ
valid
show
consist
high
predict
perform
five
test
set
vitro
human
liver
cell
vivo
anim
toxic
experi
predictor
also
demonstr
util
evalu
differ
degre
toxic
respons
drug
concentr
may
use
discern
compound
gener
hepatotox
also
determin
toxic
concentr
liver
primari
organ
metabol
detoxif
bodi
major
target
drug
toxic
bandara
kennedi
liver
toxic
hepatotox
one
critic
issu
drug
develop
lead
failur
drug
candid
preclin
clinic
studi
jaeschk
et
al
biochem
druginduc
liver
injuri
could
character
hepatocellular
predominantli
initi
alanin
transferas
alt
elev
cholestat
initi
alkalin
phosphatas
alp
rise
type
convent
hepatotox
effect
novel
compound
evalu
vivo
experi
rodent
anim
system
alt
level
three
time
upper
limit
normal
uln
usual
consid
signific
liver
injuri
even
though
histopatholog
also
frequent
tool
detect
hepatotocix
without
alt
elev
anim
vivo
anim
test
hepatocellular
toxic
resembl
physiolog
microenviron
human
bodi
nevertheless
vivo
assay
feasibl
screen
larg
number
candid
compound
due
high
cost
time
cell
cultur
biochem
system
also
frequent
use
evalu
potenti
druginduc
liver
toxic
vitro
test
cheaper
faster
conveni
screen
mani
candid
drug
compound
hepatotox
compar
vivo
analysi
yang
et
al
howev
even
though
test
wide
use
examin
activ
import
biomark
protein
express
activ
vitro
system
gener
fulli
reflect
hepatocellular
toxic
effect
alt
induct
toxic
relat
vivo
metabolit
mitochondria
dysfunct
attempt
circumv
limit
current
vitro
system
sought
develop
vitro
cellbas
predict
techniqu
effect
use
identifi
hepatotox
compound
techniqu
base
multigen
express
predictor
discrimin
wide
rang
hepatotox
compound
anim
human
liver
cell
use
expressionregul
biomark
liver
toxic
share
two
system
also
sinc
specif
molecular
mechan
hepatocellular
toxic
among
variou
compound
often
differ
identifi
use
express
signatur
commonli
associ
elev
serum
alt
level
among
multipl
heterogen
compound
use
predictor
test
wide
rang
candid
compound
hepatocellular
toxic
across
vivo
rodent
vitro
human
liver
cell
system
five
independ
test
set
structur
mechanist
divers
chemic
compound
drug
mani
studi
indic
comput
approach
structur
bioinformat
chou
molecular
dynam
lian
et
al
wang
et
al
molecular
dock
chou
et
al
predict
drugtarget
interact
et
al
protein
subcellular
locat
predict
chou
chou
shen
chou
shen
antimicrobi
peptid
predict
hiv
proteas
cleavag
site
predict
chou
signal
peptid
predict
chou
shen
identifi
gpcr
type
xiao
et
al
estim
upperlimit
enzymesubstr
reaction
rate
chou
zhou
predict
network
substrateenzymeproduct
triad
chen
et
al
well
seri
userfriendli
webserv
chou
shen
time
provid
use
inform
insight
complex
biolog
biomed
investig
novel
drug
develop
present
studi
also
attempt
develop
novel
genom
predict
techniqu
screen
hepatotox
compound
hope
may
becom
use
tool
earli
drug
discoveri
develop
order
develop
use
model
predictor
biolog
system
follow
step
gener
requir
benchmark
dataset
construct
select
ii
mathemat
formul
statist
sampl
concern
iii
oper
algorithm
engin
iv
anticip
accuraci
v
webserv
establish
chou
elabor
procedur
studi
follow
six
previouslypublish
microarray
set
vivo
rodent
vitro
human
hepatocellular
toxic
experi
use
construct
valid
predict
model
tabl
first
vivo
data
set
ncbi
geo
consist
rat
liver
sampl
hr
treatment
three
hepatocellular
toxic
compound
alphanaphthylisothiocyan
dimethylnitrosamin
nmethylformamid
three
lowtox
compound
caerulein
dinitrophenol
rosiglitazon
control
without
treatment
spicker
et
al
compound
quit
heterogen
structur
molecular
mechan
show
highli
vari
sever
cell
death
liver
complet
evalu
liver
histopatholog
indic
serum
alanin
aminotransferas
alt
aspart
aminotransferas
ast
also
avail
rat
sampl
two
addit
microarray
data
set
vivo
anim
liver
cell
treatment
toxic
compound
obtain
nation
institut
environment
health
scienc
nieh
http
cebsniehsnihgov
chou
bushel
two
studi
commonlyus
drug
compound
acetaminophen
respect
administ
consecut
hr
differ
dose
concentr
evalu
level
acut
toxic
vivo
anim
two
compound
shown
elev
alt
high
dose
bushel
et
al
umemura
et
al
base
known
toxic
two
compound
sampl
classifi
two
group
lowtox
dose
includ
untreat
control
hightox
drug
compound
alt
data
set
also
provid
recent
public
chou
bushel
final
vivo
microarray
data
set
obtain
public
domain
ncbi
geo
site
fielden
et
al
data
set
includ
rat
liver
sampl
treat
structur
mechanist
divers
chemic
compound
includ
variou
fda
approv
drug
experiment
compound
environment
toxin
control
sampl
untreat
anim
analysi
first
remov
gene
larg
proport
eg
miss
express
valu
array
data
select
among
sampl
exclud
sampl
miss
valu
evalu
hepatocellular
toxic
predict
classifi
compound
two
group
toxic
lowtox
base
report
toxicolog
inform
micromedex
databas
http
wwwmicromedexcom
compound
classifi
hepatotox
agent
report
elev
alt
level
human
rat
compound
without
elev
alt
record
rare
hepatocellular
toxic
case
report
micromedex
consid
lowtox
prior
silico
toxic
predict
addit
uncertainti
micromedex
databas
inform
compound
concentr
compound
report
micromedex
databas
exactli
compar
use
anim
experi
toxic
level
experi
unclear
nevertheless
sinc
set
consist
larg
number
compound
test
whether
good
statist
separ
hepatotox
predict
score
among
broadlyclassifi
group
lowtox
toxic
compound
treat
untreat
control
first
vitro
human
liver
cell
dataset
obtain
ncbi
geo
gene
express
omnibu
site
http
wwwncbinlmnihgovgeo
set
includ
human
hepatomaderiv
cell
line
sampl
exposur
six
heavi
metal
arsen
cadmium
nickel
antimoni
mercuri
chromium
three
compound
dmnq
phenol
nnitrosodimethylamin
dmn
kawata
et
al
celllin
system
wide
use
experiment
model
toxicolog
studi
sinc
retain
activ
phase
ii
enzym
induc
activ
detoxif
reaction
kassi
knasmul
gene
express
profil
conduct
cell
follow
treatment
compound
base
inform
micromedex
databas
classifi
phenol
lowtox
eight
compound
hepatocellular
toxic
prior
analysi
second
vitro
human
liver
cell
dataset
perform
us
environment
protect
agenc
report
toxic
evalu
three
triazol
antifung
myclobutanil
myc
propiconazol
ppz
triadimefon
tdf
ncbi
geo
site
gene
express
profil
conduct
primari
human
hepatocyt
phh
anoth
widelyus
human
cell
type
toxic
studi
follow
treatment
compound
high
medium
low
dose
base
toxic
inform
pesticideinfo
site
http
wwwpesticideinfoorg
micromedex
databas
ppz
tdf
classifi
toxic
compound
wherea
myc
consid
lowtox
compound
analysi
six
data
set
set
use
multigen
model
develop
sinc
accur
measur
alt
level
avail
multipl
structur
molecularmechanist
divers
compound
set
microarray
data
set
use
identifi
coxen
biomark
show
concord
gene
express
network
vivo
rat
vitro
human
liver
cell
remain
set
use
biomark
discoveri
model
manner
use
independ
evalu
multigen
hepatotox
predict
model
coxen
coexpress
extrapol
algorithm
origin
develop
identifi
gene
concordantli
express
regul
two
independ
cancer
system
eg
vitro
nci
celllin
panel
vivo
breast
cancer
patient
set
util
common
gene
set
crosssystem
vitro
vivo
drug
activ
predict
lee
et
al
brief
coxen
compos
six
experiment
analysi
stepsobtain
relev
drug
activ
data
train
set
molecular
express
data
train
test
set
initi
drugact
biomark
discoveri
train
set
subselect
coxen
biomark
concordantli
express
vivo
vitro
system
multivari
predict
model
coxen
biomark
train
set
adapt
algorithm
vitro
hepatotox
predict
predictor
develop
made
five
sequenti
analysi
step
figur
first
identif
initi
hepatotox
biomark
use
set
identifi
gene
whose
express
chang
consist
highli
correl
vari
alt
level
upon
treatment
multipl
compound
use
rankbas
spearman
correl
test
fdr
fals
discoveri
rate
qvalu
order
reduc
numer
fals
posit
highthroughput
profilingbas
discoveri
recent
paper
chou
et
al
also
shown
potenti
correl
approach
identifi
hepatotox
biomark
gene
chou
bushel
second
step
homolog
gene
match
human
rat
base
hugo
gene
nomenclatur
homolog
gene
human
microarray
repres
identifi
hepatotox
biomark
identifi
rat
microarray
gene
inform
microarray
platform
six
set
also
compar
annot
match
third
step
select
coxen
biomark
among
humanhomolog
hepatotox
biomark
obtain
second
step
among
initi
hepatotox
biomark
discov
vivo
set
triag
coxen
biomark
show
concord
express
network
pattern
vivo
rat
vitro
human
liver
cell
step
use
secondord
correl
analysi
identifi
common
gene
network
similarli
coexpress
due
similar
coregul
two
independ
system
technic
detail
coxen
analysi
found
elsewher
lee
et
al
note
step
use
toxic
inform
second
set
fourth
step
identifi
subset
coxen
biomark
whose
molecular
mechan
known
directli
relat
liver
toxic
function
gene
select
perform
order
develop
parsimoni
predict
model
especi
biomark
whose
function
directli
relev
hepatocellular
toxic
mechan
possibl
mani
differ
subset
coxen
biomark
found
equal
predict
preliminari
analysi
biolog
function
analysi
gene
perform
ingenu
pathway
analysi
softwar
ipa
wwwingenuitycom
redwood
citi
ca
examin
biolog
function
toxicolog
mechan
among
coxen
biomark
final
step
step
multivari
predict
model
construct
microarray
intens
valu
first
standard
within
gene
set
order
reduc
bias
express
distribut
six
independ
data
set
obtain
differ
experiment
set
base
final
biomark
obtain
step
construct
multivari
classif
model
stratifi
liver
injuri
caus
chemic
compound
contrast
toxiccompound
treat
anim
untreat
control
anim
set
next
appli
princip
compon
analysi
reduc
high
dimens
final
biomark
small
number
multigen
score
subsequ
classif
model
use
train
predict
model
base
standard
linear
discrimin
analysi
lda
techniqu
output
lda
predict
model
posterior
probabl
hepatotox
nontox
toxic
high
predict
score
posterior
probabl
close
one
subject
impli
severelyinjur
liver
cell
high
vivo
toxic
wherea
low
predict
score
close
zero
suggest
uninjur
liver
cell
low
vivo
toxic
logit
score
lda
probabl
log
plot
compar
toxic
nontox
compound
group
improv
statist
comparison
predict
probabl
score
close
zero
statist
predict
model
differ
valid
strategi
use
examin
predictor
effect
robust
practic
applic
nfold
crossvalid
jackknif
independ
setbas
test
chou
chou
zhang
chou
shen
gu
et
al
kandaswami
et
al
masso
vaisman
mohabatkar
zakeri
et
al
zeng
et
al
zhou
et
al
one
set
model
train
test
crossvalid
jackknif
strategi
use
would
still
highli
desir
valid
final
predict
model
complet
independ
test
set
avoid
multipl
comparison
pitfal
among
astronom
larg
number
compet
model
high
throughputbas
predict
model
sinc
multipl
independ
set
model
valid
test
perform
final
predict
model
simultan
six
divers
test
set
vivo
anim
vitro
human
liver
cell
across
divers
compound
unalt
classif
model
establish
set
partial
set
coxen
step
without
toxic
outcom
simultan
appli
set
evalu
want
see
predict
posterior
probabl
score
hepatotox
could
statist
discrimin
anim
human
liver
cell
treat
toxic
compound
untreat
control
treat
lowtox
compound
statist
signific
differ
score
first
evalu
use
twosampl
ttest
toxic
lowtox
control
group
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
calcul
summar
predict
perform
sensit
specif
ppv
npv
defin
predefin
cutoff
valu
predict
score
requir
order
evalu
indic
defin
optim
cutoff
valu
receiv
oper
characterist
roc
curv
analysi
perform
set
base
predict
score
hepatotox
report
toxic
inform
set
optim
cutoff
roc
curv
determin
maxim
socal
youden
index
youden
initi
biomark
discoveri
step
result
hepatocellular
toxic
biomark
highli
associ
alt
level
set
spearman
correl
test
fdr
qvalu
figur
next
annot
match
step
result
common
gene
rat
human
microarray
data
set
six
studi
step
high
proport
initi
toxic
biomark
could
match
among
four
differ
crossspeci
genomewid
array
platform
six
studi
appli
coxen
step
common
gene
identifi
concord
gene
express
network
pattern
dataset
pearson
correl
associ
pvalu
next
select
gene
known
play
role
liver
toxic
cell
death
base
ingenu
pathway
analysi
ipa
softwar
step
obtain
biomark
whose
known
biolog
function
close
relat
hepatocellular
toxic
particular
group
cellular
death
biomark
gene
hypergeometr
test
liver
toxic
biomark
gene
hypergeometr
test
found
among
significantli
overrepres
molecular
function
toxic
mechan
gene
tabl
select
hepatotox
function
gene
led
final
biomark
gene
biomark
hepatotox
predict
model
particular
found
eight
biomark
wellknown
liver
toxic
gene
kdr
mgmt
ran
vtn
highlight
tabl
surprisingli
member
cytochrom
cyp
gene
famili
encod
monooxygenas
catalyz
variou
reaction
involv
drug
metabol
estabrook
includ
list
major
gene
also
relev
cellular
death
process
gene
appear
reflect
biolog
respons
toxic
liver
cell
injur
undergon
cell
death
ran
also
known
relat
mitochondri
dysfunct
zhou
et
al
hepatotox
biomark
show
consist
express
pattern
within
toxic
nontox
compound
group
despit
divers
toxic
characterist
differ
biolog
system
cluster
analysi
figur
perform
hierarch
cluster
analysi
biomark
simultan
two
test
dataset
standard
gene
subtract
mean
divid
standard
deviat
within
set
coclust
two
set
withinspeci
withingen
normal
effect
enabl
us
combin
two
heterogen
array
dataset
result
coclust
heatmap
show
gene
express
pattern
cluster
base
report
compound
toxic
regardless
speci
potenti
differ
mechan
toxic
biomark
also
found
cluster
five
subfunct
categori
calcium
bind
catalyt
activ
cell
prolifer
morphogenesi
cytokin
inflammatori
respons
peptidas
activ
respons
drug
dna
repair
cytotox
tcell
differenti
pathway
analysi
also
perform
gene
ingenu
pathway
analysi
figur
evalu
perform
model
three
vivo
rat
dataset
tabl
toxic
compound
strongli
depend
given
dose
exampl
acetaminophen
apap
quit
safe
low
dose
liver
toxic
observ
high
dose
fact
high
dose
acetaminophen
caus
hepatocellular
toxic
acetaminophen
intox
report
one
lead
caus
liver
failur
us
bushel
et
al
examin
multigen
model
predict
abil
distinguish
nontox
toxic
dose
level
first
appli
multigen
predict
model
rat
liver
data
set
two
studi
two
compound
acetaminophen
administ
consecut
hr
rat
differ
dose
evalu
acut
toxic
set
compar
predict
score
highdos
lowdos
group
includ
control
student
twosampl
ttest
figur
predict
score
two
compound
plot
two
subpanel
hr
drug
treatment
case
highli
signific
differ
found
high
low
dose
group
hr
drug
treatment
set
p
particular
predict
score
low
dose
group
significantli
lower
high
dose
group
two
group
could
complet
distinguish
optim
cutoff
valu
maxim
yuden
index
sensit
contrari
signific
differ
found
high
low
dose
group
hr
drug
administr
p
p
result
appear
consist
pharmacokinet
observ
indic
gener
take
hr
observ
toxic
induc
chang
gene
transcript
liver
cell
signific
elev
alt
gener
observ
hr
administr
compound
http
stine
et
al
next
applic
use
independ
larg
rat
liver
dataset
test
multigen
model
set
includ
rat
liver
sampl
treatment
divers
chemic
compound
preclassifi
toxic
low
toxic
compound
use
micromedex
databas
describ
method
materi
use
model
predict
hepatotox
individu
anim
three
group
treat
toxic
compound
lowtox
compound
placebo
untreat
control
three
time
point
drug
treatment
hr
day
day
predict
larg
set
complic
due
sever
uncertain
factor
compound
ambigu
toxic
inform
micromedex
databas
absenc
inform
describ
experiment
dose
compound
valid
studi
thu
test
whether
predictor
show
statist
signific
differ
predict
toxic
score
among
broadlyclassifi
group
compound
expect
toxic
predict
result
group
noisier
yet
abl
significantli
discrimin
three
group
figur
predict
score
anim
treat
toxic
compound
significantli
higher
control
sampl
nontox
compound
treat
sampl
two
sampl
ttest
pvalu
furthermor
gradual
higher
predict
score
also
observ
among
control
lowtox
toxic
anim
group
sampl
within
hr
day
drug
administr
figur
howev
differ
control
lowtox
group
found
gradual
less
distinguish
day
drug
administr
timedepend
loss
predict
toxic
low
toxic
group
may
reflect
metabol
clearanc
compound
time
consist
literatur
rat
report
adapt
low
toxin
liver
rapidli
recov
injuri
william
iatropoulo
sinc
hepatotox
predictor
built
base
common
express
signatur
highli
associ
elev
serum
alt
level
quantit
evalu
reliabl
model
actual
report
rat
alt
level
shown
figur
high
correl
predict
coxen
score
experiment
alt
level
p
valu
spearman
correl
coeffici
independ
set
result
valid
predict
perform
also
impli
predictor
appli
quantit
predict
hepatotox
sinc
goal
build
predict
model
could
use
vitro
system
simultan
reflect
vivo
hepatotox
appli
ident
predictor
two
vitro
human
liver
cell
dataset
set
includ
cell
sampl
treat
eight
toxic
compound
one
lowtox
compound
control
group
set
predict
hepatotox
score
sampl
treat
toxic
compound
significantli
higher
treat
lowtox
compound
control
sampl
ttest
pvalu
tabl
perfect
stratif
figur
set
primari
hepatocyt
treat
two
toxic
ppz
tdf
one
lowtox
myc
antifung
compound
dose
untreat
control
cell
also
includ
order
evalu
predict
divid
drug
set
high
low
dose
group
control
shown
figur
predict
score
significantli
differ
toxic
compound
ppz
tdf
ttest
respect
furthermor
predict
hepatotox
score
higher
toxic
compound
ppz
tdf
contrari
dosedepend
effect
seen
myc
nontox
compound
pvalu
result
indic
multigen
model
could
distinguish
differ
dose
compound
well
differ
toxic
nontox
compound
studi
develop
vitro
cellbas
molecular
predictor
hepatotox
demonstr
perform
divers
independ
toxic
test
set
vivo
anim
vitro
human
liver
model
across
compound
vitrobas
predictor
also
show
abil
distinguish
toxic
nontox
dose
singl
drug
thu
believ
vitro
test
could
potenti
use
earli
phase
drug
discoveri
examin
put
hepatotox
rel
larg
number
small
molecul
facilit
select
candid
vivo
toxic
studi
howev
note
predictor
develop
replac
vivo
anim
system
provid
effici
vitro
test
predict
drug
hepatotox
complement
standard
vivo
animalbas
liver
injuri
test
also
predictor
construct
predict
druginduc
idiosyncrat
liver
injuri
develop
base
studi
larg
patient
popul
would
requir
extrem
high
sensit
predict
model
util
consist
express
signatur
across
two
system
vivo
rat
vitro
human
liver
cell
result
high
predict
perform
system
use
crossspeci
intersystem
predict
model
predict
perform
consist
shown
five
vitro
vivo
test
set
treat
divers
chemic
drug
compound
differ
array
platform
multigen
predictor
also
show
abil
stratifi
differ
toxic
dose
differ
degre
toxic
elaps
time
point
treatment
work
differ
earlier
studi
describ
molecular
signatur
specif
one
biolog
system
fielden
et
al
zidek
et
al
addit
previou
toxicogenom
studi
train
set
test
set
experi
model
train
intern
valid
howev
often
subject
select
bia
due
bia
specif
microarray
assay
platform
use
multipl
comparison
pitfal
highthroughput
profilingbas
predict
model
model
frequent
fail
perform
well
independ
toxic
studi
fielden
et
al
stress
current
studi
avoid
pitfal
valid
five
independ
data
set
differ
experiment
set
microarray
platform
test
set
includ
structur
molecularmechanist
divers
chemic
compound
includ
variou
fda
approv
drug
experiment
compound
environment
toxin
still
exist
sever
critic
limit
vitrobas
cell
system
instanc
differ
compound
may
induc
differ
form
liver
toxic
eg
cell
death
metabol
perturb
andor
mitochondria
dysfunct
could
result
uniqu
gene
express
profil
even
though
select
genom
biomark
commonli
associ
multipl
heterogen
toxic
clinicallyus
compound
circumv
difficulti
predictor
would
abl
accur
predict
mani
differ
mechan
liver
toxic
degre
nevertheless
believ
studi
provid
proof
concept
use
vitro
cell
test
evalu
hepatotox
hope
stimul
addit
work
area
also
believ
gene
signatur
refin
data
liver
toxic
becom
avail
second
limit
use
data
develop
predict
gene
set
cell
lack
metabol
mechan
differ
mani
biolog
characterist
vivo
model
despit
limit
predictor
could
predict
toxic
mani
compound
human
primari
hepatocyt
suggest
molecular
express
signatur
deriv
common
gene
induc
toxic
compound
rat
liver
human
cell
may
provid
accur
reflect
human
liver
sever
addit
limit
may
exist
predict
model
first
develop
appli
predictor
vivo
system
demonstr
model
predict
perform
vivo
injuri
model
due
data
set
avail
train
independ
evalu
therefor
chang
gene
express
occur
earli
time
point
eg
hour
dose
captur
model
may
use
predict
toxic
compound
elev
alt
hr
treatment
nevertheless
sinc
goal
develop
effici
vitro
model
use
screen
earli
stage
candid
drug
compound
believ
toxic
predictor
still
highli
use
effect
unless
compound
toxic
greatli
diminish
hr
cytochrom
enzym
play
import
role
detoxif
clearanc
toxic
compound
express
level
activ
enzym
often
use
predict
potenti
problem
compound
metabol
drugdrug
interact
studi
indic
addit
function
class
gene
highli
predict
hepatotox
inflammatori
gene
gene
encod
protein
involv
dna
repair
consequ
multigen
predictor
heavili
bias
toward
gene
encod
enzym
activ
lack
emphasi
gene
express
gene
signatur
rais
possibl
futur
may
possibl
predict
hepatox
use
cultur
cell
line
interestingli
gene
signatur
also
includ
gene
ran
may
directli
associ
mitochondri
dysfunct
xia
et
al
zhou
et
al
select
final
hepatotox
function
biomark
among
coxen
biomark
somewhat
subject
within
limit
knowledg
gene
current
known
involv
hepatocellular
toxic
may
exist
mani
equal
highli
predict
multigen
model
hepatotox
howev
search
optim
model
highest
predict
power
comput
feasibl
due
astronom
number
candid
multigen
model
overfit
pitfal
rel
small
number
train
sampl
compar
perform
functionallyselect
model
randomli
select
model
predict
model
found
within
top
base
auc
area
curv
comparison
overal
predict
furthermor
found
biomark
show
distinct
express
pattern
among
differ
subfunct
categori
figur
exampl
dna
repair
cytotox
tcell
differenti
biomark
overexpress
among
toxictr
anim
human
liver
cell
biomark
peptidas
activ
drug
respons
underexpress
group
anim
liver
human
liver
cell
therefor
even
though
model
may
highli
perform
predict
model
believ
perform
consist
well
two
system
variou
toxic
compound
provid
direct
biolog
insight
drug
liver
toxic
investig
understand
hepatocellular
toxic
gene
mechan
sinc
number
biomark
final
model
may
still
rel
larg
need
investig
whether
parsimoni
model
fewer
biomark
provid
equal
even
highli
predict
stratifi
toxic
compound
also
often
done
similar
studi
chou
shen
userfriendli
publicli
access
webserv
bioinformat
algorithm
quit
use
develop
mani
predictor
model
make
continu
effort
develop
webserv
hepatocellular
toxic
predict
develop
five
distinct
step
first
identif
hepatocellular
toxic
biomark
gene
correl
analysi
serum
alt
second
homolog
gene
match
human
rat
third
select
coxen
biomark
among
humanhomolog
hepatocellular
toxic
biomark
obtain
second
step
fourth
step
select
biomark
known
directli
relat
liver
toxic
cell
death
perform
ingenu
pathway
analysi
function
analysi
step
led
final
biomark
hepatocellular
toxic
last
step
multivari
predict
model
construct
base
final
gene
two
test
set
univers
hepatocellular
toxic
biomark
standard
subtract
mean
divid
standard
deviat
gene
within
set
combin
hierarch
cluster
analysi
combin
set
sampl
vivo
rat
vitro
human
liver
cell
found
well
stratifi
toxic
nontox
control
compoundtr
one
five
function
subclust
biomark
identifi
examin
common
biolog
function
gene
subclust
affymetrix
function
analysi
tool
netaffx
b
pathway
analysi
also
perform
gene
comparison
coxen
score
rat
set
treat
low
dose
high
sublethaldos
predict
score
two
compound
plot
two
subpanel
hr
drug
treatment
applic
anim
treat
high
sublethaldos
hr
could
perfectli
discrimin
low
dose
predict
model
c
comparison
coxen
predict
score
control
rat
set
without
treatment
rat
treat
lowtox
toxic
compound
toxic
low
toxic
compound
defin
micromedex
databas
wwwmicromedexcom
predict
score
compound
plot
three
subpanel
hr
day
day
drug
treatment
statist
signific
p
valu
set
predict
assess
two
sampl
ttest
predict
score
hepatotox
highli
associ
experiment
observ
alt
level
anim
across
entir
rang
liver
toxic
spearman
pvalu
comparison
coxen
score
cell
treat
low
toxic
includ
control
toxic
compound
predict
score
sampl
treat
toxic
compound
significantli
higher
treat
lowtox
compound
control
sampl
pvalu
b
comparison
coxen
score
primari
human
hepatocyt
treat
high
dose
low
dose
three
compound
myclobutanil
myc
propiconazol
ppz
triadimefon
tdf
base
toxic
inform
pesticideinfo
site
http
wwwpesticideinfoorg
ppz
tdf
classifi
toxic
compound
wherea
myc
consid
lowtox
compound
predict
score
significantli
differ
toxic
compound
ppz
tdf
respect
furthermor
predict
hepatocellular
toxic
score
higher
among
toxic
dose
group
contrari
predict
score
low
high
dose
group
lowtox
compound
myc
statist
differ
tabl
predict
result
independ
test
set
use
independ
evalu
classif
perform
hepatocellular
toxic
predict
model
want
see
predict
score
hepatocellular
toxic
could
statist
discrimin
cell
anim
treat
toxic
compound
one
treat
nontox
compound
untreat
control
set
statist
signific
differ
score
first
evalu
use
twosampl
ttest
toxic
nontox
group
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
calcul
sensit
specif
ppv
npv
defin
tabl
select
toxic
relat
gene
correl
alt
level
data
set
gene
identifi
correl
analysi
alt
level
coxen
algorithm
biolog
function
analysi
gene
sort
qvalu
deriv
fdr
calcul
eight
gene
directli
relat
liver
toxic
highlight
